Libyan Endemic Medicinal Plants for Patients with HCV and Those Undergoing Dialysis: Future Perspectives
DOI:
https://doi.org/10.54361/ajmas.261138Keywords:
Endemic plants, Bioactive compounds, Anti-HCV, Kidney disease, Libya, EfficacyAbstract
This paper focuses on endemic plants in Libya and their medicinal use, particularly their antiviral activity, specifically their antiviral activity in treating HCV cases in Haemodialysis Units (HD). It emphasises the active constituents of these plants and presents data accurately collected from recent research published in trustworthy internet sources, including PubMed, ScienceDirect, Scopus, Google Scholar, and Wiley. Among these publications. Notably, the Asteraceae family emerged as the most dominant family, featuring three species. The literature also presented numerous medicinal plants that effectively managed HCV infections. A comprehensive list of 12 medicinal plants belonging to 8 families showed beneficial action against HCV and kidney illness. The major bioactive compounds implicated in the kidney therapy have been identified. These compounds include Polyphenols such as phenolic acids, flavonoids, and tannins. By recognising the therapeutic properties of these endemic plants, we can enhance treatment options for HCV and related kidney disease complications. Moreover, many of the polyphenols showed anti-HCV activity. The use of these natural compounds is fundamental due to their lower production costs, as they are not chemically synthesised. Understanding these therapeutic properties leads to the development of effective treatment for both HCV and kidney disease complications.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Muna Ibrahim

This work is licensed under a Creative Commons Attribution 4.0 International License.











